Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant

Authors :: Stefania Paolini
Francesco Barbato
Sarah Parisi
Chiara Sartor
Valentina Robustelli
Giovanni Marconi
Nicoletta Testoni
Antonio Curti
Mario Arpinati
Gianluca Cristiano
Michele Cavo
Simona Soverini
Jacopo Nanni
Elisabetta Zappone
Gabriella Chirumbolo
Cristina Papayannidis
Francesca Bonifazi
Carolina Terragna
Alida Dominietto
Papayannidis C.
Sartor C.
Dominietto A.
Zappone E.
Arpinati M.
Marconi G.
Cristiano G.
Nanni J.
Parisi S.
Barbato F.
Paolini S.
Soverini S.
Terragna C.
Robustelli V.
Testoni N.
Chirumbolo G.
Curti A.
Cavo M.
Bonifazi F.
Source :: Hematological Oncology. 39:580-583
Publication Year :: 2021
Publisher :: Wiley, 2021.
Abstract: NA

Tools